Cargando…
Genome-Wide Profiling of the Toxic Effect of Bortezomib on Human Esophageal Carcinoma Epithelial Cells
OBJECTIVES: Bortezomib has been widely used to treat multiple myeloma and other hematological malignancies. However, not much is known about its effect on solid tumors. The aim of this study was to study the effect of Bortezomib on human esophageal cancer cell lines and investigate the potential tar...
Autores principales: | Ao, Nannan, Dai, Yingchu, Chen, Qianping, Feng, Yang, Yu, Jingping, Wang, Chang, Liu, Fenju, Li, Ming, Liu, Geng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457034/ https://www.ncbi.nlm.nih.gov/pubmed/30961474 http://dx.doi.org/10.1177/1533033819842546 |
Ejemplares similares
-
Identification of Genes Affecting the Toxicity of Anti-Cancer Drug Bortezomib by Genome-Wide Screening in S. pombe
por: Takeda, Kojiro, et al.
Publicado: (2011) -
Bortezomib/ibrutinib/rituximab: Various toxicities: case report
Publicado: (2021) -
Progress on the Application of Bortezomib and Bortezomib-Based Nanoformulations
por: Liu, Jianhao, et al.
Publicado: (2021) -
Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma
por: Chen, Chen, et al.
Publicado: (2015) -
Combined Effect of Bortezomib and Menadione Sodium Bisulfite on Proteasomes of Tumor Cells: The Dramatic Decrease of Bortezomib Toxicity in a Preclinical Trial
por: Astakhova, Tatiana M., et al.
Publicado: (2018)